- The technology from IOMED Medical Solutions significantly reduces the time needed to obtain data for clinical research
- The implementation of this tool will facilitate Fundació Puigvert’s participation in multicentric big data and AI projects, which will improve and optimize the treatment of future patients
Barcelona, July 21, 2022.-Fundació Puigvert will enhance its research with the artificial intelligence tool developed by IOMED Medical Solutions, which will automate access to clinical data for hospital researchers in order to develop more studies in less time, with a large volume of data and at a lower cost. “We already have the first two candidate projects, one in uro-oncology and another in hereditary kidney disease, using IOMED’s technology. We are in the implementation phase and expectations are high as a tool to enhance research in our center,” explains Dr. Sílvia Mateu, research coordinator at Fundació Puigvert.
“This tool will allow our participation in multicentric big data and artificial intelligence projects that will expand knowledge not only in highly prevalent pathologies such as various urogenital tumors or chronic kidney disease but also in the field of rare minority diseases where having a large number of cases through collaboration with many centers in coordination is essential,” comments Dr. Mateu. “Sharing data on a large scale provides a lot of information about the real experience of patients treated or followed in the studied pathologies, information that would otherwise be impossible to know. The results of big data studies and AI are essential for improving and optimizing the future management and treatment of patients. They have the potential to achieve more effective and personalized medicine,” she adds.
Javier d’Oca, CEO and co-founder of IOMED, points out about the alliance: “It will enable healthcare professionals and researchers to access the data stored in a tenth of the time it would take for a manual data extraction.”
Anonymization of data
The tool has been provided by IOMED Medical Solutions to Fundació Puigvert free of charge. It is responsible for transforming the data from clinical histories written in free text (clinical notes, clinical courses, medical reports of diagnostic tests, discharge reports, surgical intervention reports, etc.) into coded data using standard clinical vocabularies (SNOMED, ICD-9, ICD-10, LOINC, etc.). This transformation is carried out using artificial intelligence algorithms and natural language processing that structure all the written information. The data is anonymized and stored on the hospital’s servers, which will maintain its governance and custody at all times.
Federated European Clinical Research Network
IOMED is part of the EDHEN project, which seeks to create a federated network of medical data at the European level to improve health research. Within this European initiative, IOMED has processed data from over 18 million patients.
“Data structuring is the primary basis for big data and artificial intelligence projects to address the study of uro-nephro-andrological pathologies in the real-world environment (real world data). The transformation of data into OMOP standards will facilitate the execution of internal research projects and, above all, will allow us to participate in a more standardized, easy, and agile way in large-scale projects promoted by both private companies and collaborative groups of independent research. We will be able to participate in large-scale projects at the European level where this technology is preferred,” indicates the research coordinator of Fundació Puigvert.
Javier d’Oca, CEO and co-founder of IOMED, highlights the importance of this agreement. “This agreement will allow Fundació Puigvert to be at the forefront of global clinical research.”

